INTRODUCTION
============

*Staphylococcus aureus* is an important human pathogen, and methicillin-resistant *S. aureus* (MRSA) has become a major cause of hospital- and community-acquired infection. Methicillin resistance rates in Korean hospitals have increased during recent decades, and MRSA reportedly accounts for 60-70% of all *S. aureus* isolates in tertiary hospitals in Korea. In 2009, the MRSA rate in Korea was reported to be as high as 81% in tertiary hospitals and 40% in non-tertiary hospitals \[[@B1]\].

In the United States of America (USA), Europe, and some parts of Asia, the incidence of MRSA has been monitored for prolonged periods to establish a national database of the multidrug-resistant clones distributed worldwide \[[@B2]\]. In the USA, USA300 and USA400 are the major clones frequently isolated in community-associated (CA) MRSA, and monitoring has provided a basis for the identification of toxic genes in these clones. Such monitoring allows for the recognition of outbreaks, and these clones provide a basis for monitoring the propagation and spread of domestic and international clones \[[@B3]\]. Monitoring efforts provide insights into the causes of increased resistance, which may be related to resistance obtained by various clones or to infection control measures, in which antibiotics select specific resistant bacteria. Additionally, monitoring tracks the rapid spread of bacteria among hospitals or between hospitals and the community, and helps evaluate the effects of increasing international travel and trade exchanges on the appearance of new resistant strains. Therefore, for effective analysis of the propagation of multidrug-resistant strains, the molecular epidemiological characteristics of domestic strains must be determined and compared with those of foreign strains.

Accordingly, the USA, Japan, Europe, and Denmark have established national organizations for compiling molecular epidemiologic information about multidrug-resistant strains of bacteria associated with infectious diseases, thereby allowing the monitoring of the prevalence of multidrug-resistant bacteria in the community or hospitals \[[@B4][@B5][@B6]\]. In Korea, specific analysis and monitoring have been performed only in some tertiary institutions at the national level, which makes the analysis of propagation patterns or trends difficult. Therefore, the identification of clones through the molecular genetic analysis of major resistant bacteria would improve our understanding of the propagation of MRSA and facilitate the establishment of disease management measures.

In this study, we identified major clones by targeting *S. aureus* isolated from medical care hospitals, including a geriatric hospital, in Korea. We analyzed the molecular genetic characteristics, classification, and characterization of MRSA isolates as well as the trends of national epidemic strains to identify resistant strains.

METHODS
=======

1. Bacterial strains and their identification
---------------------------------------------

Samples were collected from hospitals that participated in the National Antimicrobial Surveillance Project; they were randomly and evenly selected from 10 districts (including Seoul, Gyeonggi-do/Incheon, Gangwon-do, Chungcheongbuk-do, Chungcheongnam-do/Daejeon, Gyeongsangbuk-do/Daegu/Ulsan, Gyeongsangnam-do/Busan, Jeollanam-do/Gwangju, Jeollabuk-do, and Jejudo) nationwide. A total of 986 *S. aureus* strains isolated from the surveillance cultures of clinical patients at general hospitals, hospitals and clinics, and geriatric hospitals between 2001 and 2008 were analyzed in this study. Most of the general hospitals were sentinel surveillance hospitals, and some isolates were identified by hospital-affiliated laboratories before the specimens were sent to Division of Antimicrobial Resistance, Korea National Institute of Health (KNIH).

Bacterial identification and antimicrobial susceptibility testing in this study were carried out with a VITEK 2 system (bioMérieux, La Balme les Grottes, France) and confirmed by the detection of *mecA* through PCR analysis. We used the following *S. aureus* strains: ATCC 25923, ATCC 29213, and ATCC 43300 (*mecA*, positive control) from ATCC (Manassas, VA, USA). If needed, antimicrobial susceptibility testing was performed with the disc diffusion method according to the CLSI guidelines \[[@B7]\]. *S. aureus* ATCC 29213 was used as a quality control strain for the determination of minimum inhibitory concentrations (MICs).

2. Clinical and epidemiological information
-------------------------------------------

We analyzed data collected during an 8-yr period. Formal ethical approval for this study was obtained from Institutional Review Board of the Korea Centers for Disease Control and Prevention (KCDC). As part of this analysis, basic patient data were collected, including age (≥1 yr old), sex, and specimen type. Hospitals also provided consecutive, nonduplicate isolates for molecular typing. Cases were described as CA if MRSA was isolated from patients within 48 hrs of hospital admission or from patients who had none of the following risk factors: (i) history of hospitalization or surgery in the preceding calendar year, or (ii) residence in a long-term care facility (LTCF). Otherwise, they were considered to be healthcare-associated (HA) MRSA.

3. Identification of staphylococcal cassette chromosome *mec* type and Panton-Valentine leukocidin
--------------------------------------------------------------------------------------------------

Staphylococcal cassette chromosome *mec* (SCC*mec*) types were determined with multiplex PCR \[[@B8]\]. PCR amplification for Panton-Valentine leukocidin (PVL)-encoding genes (*lukS-PV* and *lukF-PV*) was performed on representative isolates from each inferred from a multilocus sequence typing (MLST) clonal complex, as previously described \[[@B9]\].

4. Molecular typing
-------------------

For molecular typing, MLST and DiversiLab (DL; bioMérieux, Mercy l\'Etoile, France) microbial typing procedures were performed as previously described \[[@B10][@B11][@B12]\]. DL strain typing was determined via cluster analysis following the guidelines provided by the manufacturer. The isolates were categorized as indistin guishable, similar, or different according to bands interpreted using the DL analysis guide (software version 3.4).

5. Designation of Korean MRSA
-----------------------------

For the strain typing of representative MRSA isolates, all MRSAs were categorized based on a combination of genetic differences determined through SCC*mec* typing and MLST, and the presence of PVL was also analyzed. For comparisons of the designated Korean MRSA (KMRSA) strains, the DL MRSA library database on the DL website ([www.biomerieux-usa.com/diversilab](http://www.biomerieux-usa.com/diversilab)) was used.

RESULTS
=======

1. Identification of species and MRSA
-------------------------------------

The distributions of the 986 *S. aureus* isolates are shown in [Table 1](#T1){ref-type="table"}. All isolates were obtained in general hospitals (400 isolates, 40.6%), hospitals and clinics (475 isolates, 48.2%), or geriatric hospitals (111 isolates, 11.3%). Of these, 803 MRSA isolates (81.4% of the total isolates) were identified through oxacillin screening and with the *mecA* PCR method. Among all MRSA infections, 294 (36.6%) isolates were identified as CA-MRSAs with non-multidrug resistance (non-MDR; defined as susceptible to ≥2 tested non-β-lactam antibiotic drugs), and the rest (509 \[63.4%\]) were classified as HA-MRSAs. Most of the identified HA-MRSAs were recovered from invasive infections (e.g., pus \[n=150\], wounds \[n=129\], sputum \[n=97\], blood \[n=50\], urine \[n=36\], ear fluid \[n=14\], pleural fluid \[n=12\]), although 47 isolates were recovered from nasal swabs (data not shown).

2. Clonal distribution and detection of PVL
-------------------------------------------

On MLST analysis, SCC*mec* types for all MRSAs were characterized by four major clones and the results are shown in [Fig. 1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}: CC5 belonging to the SCC*mec* II type (including IIA and IIvariant), CC8 belonging to the SCC*mec* III type (including IIIA and IIIvariant), and CC72 and CC1 belonging to the SCC*mec* IV type (including IVA). All MRSAs were clonally distributed throughout the country and hospitals. Regionally, five clones-CC1, CC5, CC8, CC72, and CC89-made up the majority of the isolates, whereas CC30, CC59, CC121, and CC608 were less frequent. In general hospitals, CC5 and CC8 were distributed primarily in Seoul. CC72 was the main clone distributed in hospitals and clinics at Chungcheongnam-do/Daejeon (CN/DJ), and CC5 was widespread in geriatric hospitals at Jeollanam-do (JN) and Gyeongsangnam-do (GN). The presence of *lukF-PV* and *lukS-PV* genes encoding the components of the PVL toxin was detected in all isolates. CA-MRSA isolates most commonly had SCC*mec* II and IV type traits and no positive PVL genes (data not shown).

3. Categorization of KMRSA
--------------------------

The clones and *mec* types were classified as KMRSA-1 through KMRSA-9 and summarized in [Table 2](#T2){ref-type="table"}. KMRSA-1 was the most frequent, identified in 308 isolates (38.4% of all MRSAs), and has the genetic characteristics of CC5 and the SCC*mec* II type. In contrast, 13 isolates (1.6%) had the genetic characteristics of CC5 and the SCC*mec* IV type; therefore, these were identified as KMRSA-8. A total of 161 isolates (20.0%) had the genetic characteristics of CC8 and the SCC*mec* III type, and thus were identified as KMRSA-2, whereas 20 isolates with the SCC*mec* IV type were designated KMRSA-7. KMRSA-3 was identified in 207 isolates (25.8%) with the genetic characteristics of CC72 and the SCC*mec* IV type, whereas 11 isolates (1.4%) with the SCC*mec* II type were designated KMRSA-5. KMRSA-4 (CC1 and the SCC*mec* IV type) comprised 48 isolates (6.0%). KMRSA-6 was identified in 23 isolates (2.9%) with the genetic characteristics of CC89 and the SCC*mec* II type, and KMRSA-9 was identified in two isolates (0.2%) with the genetic characteristics of CC30 and the SCC*mec* IV type.

4. Geographical distribution of KMRSA
-------------------------------------

KMRSA was distributed in 10 regions across the country in the following numbers: Seoul, n=222; Gyeonggi-do/Incheon, n=113; Gangwon-do, n=25; Chungcheongbuk-do, n=23; Chungcheongnam-do/Daejeon, n=94; Jeollabuk-do, n=68; Jeollanam-do/Gwangju, n=47; Gyeongsangbuk-do/Ulsan/Daegu, n=91; Gyeongsangnam-do/Busan, n=109; and Jejudo, n=11 ([Fig. 3](#F3){ref-type="fig"}). KMRSA-1, KMRSA-2, and KMRSA-3 were prevalent throughout most of the country, including Seoul and Gyeonggi-do Province. KMRSA-3, KMRSA-4, and KMRSA-6 had higher distribution ratios in Daejeon, Jeollanam-do and Gwangju, and Gyeongsangnam-do, respectively.

5. Genetic relatedness of KMRSA strains
---------------------------------------

We analyzed the DL patterns of KMRSA strains by using the DL MRSA library STAT sheet, which comprises 70 samples with representative USA pulsed-field gel electrophoretic (PFGE) and SCC*mec* types. A DL typing dendrogram representing nine KMRSA strains is shown in [Fig. 4](#F4){ref-type="fig"}. The average similarity among KMRSA-1 through KMRSA-8 was more than 84%; KMRSA-9 differed from the other strains.

DISCUSSION
==========

In this study, we investigated the molecular and genetic characteristics and trends of national staphylococcal clones in hospital settings in Korea over an 8-yr period. We isolated an average of 124 strains per year nationally, and despite the limitation of the small sample numbers, we evaluated the clinical importance of the isolates.

The distribution ratio of the collected MRSA isolates (up to 81.4%) was relatively higher than that of foreign MRSA \[[@B13]\]. In particular, the average MRSA distribution for all medical settings, including hospitals, was more than 70% for all hospitals and more than 80% for LTCFs (data not shown). These results are consistent with the resistance rates reported by the Korean Antimicrobial Resistance Monitoring System (KARMS) and the Korean Nationwide Surveillance of Antimicrobial Resistance (KONSAR) \[[@B14]\]. In clinics, MRSA rates were also relatively higher (60%) than the average of 40% reported by KARMS.

In this study, we categorized KMRSA strains according to sequence type (ST), SCC*mec* type, and the presence of PVL. From this classification, we categorized the strains of MRSA on the basis of the genetic characteristics and compared domestic MRSA with MRSA strains that are epidemic in the USA, United Kingdom (UK), and Canada. Frequently observed MRSA strains, including USA100, USA400, and eclone-1, have been identified in the USA and Europe. Of the epidemic MRSA strains designated in this study, KMRSA-1, which had the highest distribution ratio, showed genetic characteristics identical to those of USA100 and Canada MRSA-2 (ST5 and SCC*mec* type II). This clone is distributed worldwide, including in Korea. KMRSA-8, which has genetic similarity to KMRSA-1, was less frequently identified but was confirmed in some areas overseas.

KMRSA-3 was identical to USA700 and was derived from local communities. Moreover, this clone had genetic similarity to the USA300 clone of PVL-positive MRSA. However, only three isolates of this domestic clone were identified, which suggested that it is not a common type. KMRSA-2 (CC8 and the SCC*mec* III type) was the third epidemic clone and differed from epidemic clones of the SCC*mec* IV type found overseas. KMRSA-7, which was genotypically identical to KMRSA-2, was uncommonly distributed and was the same as USA500 and UK-CC8. KMRSA-4 was identical to clones USA400 and UK-CC1, and KMRSA-9 was identical to USA200 and UK-CC30. KMRSA-4 and KMRSA-9 were also separated by the individual clonal types CC1 and CC30 in the community and hospitals.

KMRSA-1, KMRSA-2, and KMRSA-3 had the widest distribution nationwide and were distributed evenly in several hospitals in Gyeongsangnam-do and Busan. In particular, KMRSA-3 had relatively wide distribution in Chungcheongnam-do and Daejeon. This result may be attributable to the concentration of KMRSA-3 in specific pediatric hospitals in Daejeon, but the possibility that KMRSA-3 was trending in Daejeon at the time of the study also cannot be ruled out.

The most common lineages in the USA are CC1 (USA400) and CC8 (USA300), which usually carry SCC*mec* type IV and PVL-encoding genes and are becoming the subject of intense research \[[@B3][@B15]\]. The four PVL-positive MRSA stains in this study had ST30 (one isolate) or ST8 (three isolates) characteristics. Of these, three isolates showed the molecular characteristics of an HA-MRSA of SCC*mec* III type with the staphylococcal enterotoxin genes *sea* and *seb*, and the other showed molecular characteristics of a CA-MRSA of SCC*mec* IV type with the staphylococcal enterotoxin genes *seg* and *sei*. These results were confirmed by the observation that the USA clone of a PVL-positive community epidemic was also identified in the Korean hospital environment during various periods. Thus, these strains exhibited some genetic differences from strains in dominant countries, including the USA, Canada, and Latin America \[[@B16]\].

In summary, the methicillin resistance rate of staphylococcal isolates in Korea was slightly higher than that in other countries. Comparisons of domestic and foreign MRSA clones showed similarities in three types, and the genetic similarities to foreign clones were characterized. Some of these strains were related to those that had spread overseas, whereas others (e.g., KMRSA-2) had genetic traits, such as different SCC*mec* structures, that were nationally distributed. In addition, we confirmed that PVL-positive MRSA strains were not HA strains distributed in hospitals in Korea. Therefore, we believe that this comparative study of the genetic characteristics of epidemic MRSA clones will be a useful resource for the establishment of infection control measures in future multidrug-resistant staphylococcal outbreaks and in cases of newly occurring resistant strains related to the influx of foreign strains. Our results have also identified additional target strains that may be helpful in future monitoring efforts.
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![Clonal distribution of all methicillin-resistant *Staphylococcus aureus* (MRSA) isolates by district. The prevalence of CCs in (A) general hospitals, (B) hospitals and clinics, and (C) geriatric hospitals is shown. Singleton refers to STs that could not be assigned to any group.\
Abbreviations: CB, Chungcheongbuk-do; CN/DJ, Chungcheongnam-do/Daejeon; GB/US/DG, Gyeongsangbuk-do/Ulsan/Daegu; GG/IC, Gyeonggi-do/Incheon; GN/BU, Gyeongsangnam-do/Busan; GW, Gangwon-do; JB, Jeollabuk-do; JJ, Jejudo; JN/GJ, Jeollanam-do/Gwangju; SE, Seoul.](alm-36-536-g002){#F2}

![Geographical distribution of Korean MRSA (KMRSA).\
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![Dendrogram analysis of nine representative Korean MRSA (KMRSA) strains (circled) obtained by using the DiversiLab (DL; bioMérieux, Mercy l\'Etoile, France) MRSA library sheets. The gel-like image generated by the DL software illustrates band similarities.](alm-36-536-g004){#F4}

###### Number of *Staphylococcus aureus* isolates collected in the study

![](alm-36-536-i001)

  Administrative district        Number of isolates   Total (%)                 
  ------------------------------ -------------------- ------------ ------------ ------------
  Gangwon-do                     3                    13           13           29 (3.0)
  Seoul                          159                  75           3            237 (24.0)
  Gyeonggi-do/Incheon            59                   63           6            128 (13.0)
  Chungcheongbuk-do              10                   15           9            34 (3.4)
  Chungcheongnam-do/Daejeon      20                   93           6            119 (12.1)
  Gyeongsangbuk-do/Ulsan/Daegu   53                   57           15           125 (12.7)
  Gyeongsangnam-do/Busan         57                   74           15           146 (14.8)
  Jeollabuk-do                   9                    50           30           89 (9.0)
  Jeollanam-do/Gwangju           29                   23           14           66 (6.7)
  Jejudo                         1                    12           0            13 (1.3)
  Total (%)                      400 (40.5)           475 (48.2)   111 (11.3)   986 (100)

###### Classification of KMRSA

![](alm-36-536-i002)

  KMRSA     CC   Number of isolates by SCCmec type   Total (%)         
  --------- ---- ----------------------------------- ----------- ----- ------------
  KMRSA-1   5    308                                 \-          \-    308 (38.4)
  KMRSA-2   8    \-                                  161         \-    161 (20.0)
  KMRSA-3   72   \-                                  \-          207   207 (25.8)
  KMRSA-4   1    \-                                  \-          48    48 (6.0)
  KMRSA-5   72   11                                  \-          \-    11 (1.4)
  KMRSA-6   89   23                                  \-          \-    23 (2.9)
  KMRSA-7        \-                                  \-          20    20 (2.5)
  KMRSA-8   5    \-                                  \-          13    13 (1.6)
  KMRSA-9   30   \-                                  \-          2     2 (0.2)
  None                                                                 10 (1.2)
  Total                                                                803 (100)

Abbreviations: KMRSA, Korean methicillin-resistant *S. aureus*; CC, clonal complex; None, unclassified KMRSA type; SCC*mec*, staphylococcal cassette chromosome *mec*.
